Skip to main content
A

ATOMO DIAGNOSTICS LIMITED — Investor Relations & Filings

Ticker · AT1 ISIN · AU0000080327 ASX Manufacturing
Filings indexed 389 across all filing types
Latest filing 2026-01-14 Regulatory Filings
Country AU Australia
Listing ASX AT1

About ATOMO DIAGNOSTICS LIMITED

https://www.atomodiagnostics.com/

Atomo Diagnostics Limited specializes in the design and manufacture of integrated rapid diagnostic test (RDT) platforms. The company focuses on improving the usability and reliability of point-of-care testing through its proprietary AtomoRapid technology. This platform integrates essential components, such as a safety lancet and a calibrated blood collection system, into a single, user-friendly device. Key applications include HIV screening, COVID-19 detection, and pregnancy testing. By simplifying the testing procedure and reducing the risk of user error, the company provides solutions for both professional clinical environments and consumer self-testing markets. Its products are designed to deliver laboratory-grade accuracy in decentralized settings, supporting global health initiatives and individual health management.

Recent filings

Filing Released Lang Actions
Atomo Secures a Significant Order for HIV Self-Test 1
Regulatory Filings
2026-01-14 English
Change of Director's Interest Notice x3 6 pages 565.5KB
Regulatory Filings
2025-12-17 English
Notification regarding unquoted securities - AT1 6 pages 19.8KB
Regulatory Filings
2025-12-11 English
Change in substantial holding 3 pages 95.3KB
Regulatory Filings
2025-12-11 English
Response to ASX Price Query 3 pages 374.7KB
Regulatory Filings
2025-12-02 English
Chair's Address to Shareholders 4 pages 108.1KB
Regulatory Filings
2025-10-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.